Stock Price
4.59
Daily Change
-1.19%
Yearly
53.34%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Adma Biologics 1.45 0 0% -27.86%
Adamas Pharmaceuticals 8.22 0.06 0.74% 91.16%
BioCryst Pharmaceuticals 12.07 -0.38 -3.05% 147.84%
BioDelivery Sciences International 2.74 -0.08 -2.84% -27.89%
ChemoCentryx 35.52 -1.38 -3.74% -36.28%
Dicerna Pharmaceuticals 38.02 -0.07 -0.17% 53.53%
Dynavax Technologies 15.82 -0.25 -1.56% 200.76%
Flexion Therapeutics 9.12 -0.02 -0.22% -17.76%
Halozyme Therapeutics 32.89 -0.39 -1.17% -19.01%
Immunogen 5.90 1.15 24.11% 5.08%
Insmed 27.00 -0.12 -0.44% -31.02%
Jazz Pharmaceuticals 118.56 -3.85 -3.15% -17.17%
Kindred Biosciences 9.24 -0.01 -0.11% 120.53%
Karyopharm Therapeutics 6.81 -0.05 -0.66% -59.78%
Eli Lilly 252.64 -2.19 -0.86% 73.56%
MacroGenics 17.18 -0.73 -4.08% -27.48%
MannKind 4.59 -0.06 -1.19% 53.34%
Merck & Co 74.81 -0.08 -0.11% -8.26%
Minerva Neurosciences 1.02 0.02 1.50% -64.88%
Novavax 207.37 13.41 6.91% 67.95%
Novo Nordisk A Fs 107.30 -0.99 -0.91% 58.94%
PDL BioPharma 2.47 0 0% -23.05%
Pfizer 54.27 1.87 3.57% 37.71%
Peregrine Pharmaceuticals 30.61 0.18 0.59% 235.64%
Sanofi 83.86 -1.75 -2.04% -0.29%
Acceleron Pharma 178.75 -0.93 -0.52% 57.43%
Xencor 35.68 -0.41 -1.14% -13.54%

Indexes Price Day Year
US2000 2187 -55.33 -2.47% 19.10%
NASDAQ 15554 -229.12 -1.45% 25.89%

MannKind
MannKind Corporation is a biopharmaceutical company. The Company is focused on the development and commercialization of inhaled therapeutic products for diabetes and orphan lung diseases, such as pulmonary arterial hypertension. The Company’s lead product is Afrezza Inhalation Powder, which is an inhaled insulin indicated to improve glycemic control in adults with diabetes. Afrezza consists of a dry powder formulation of human insulin delivered from a small portable inhaler. AFREZZA utilizes its Technosphere formulation technology. The Technosphere is a drug delivery platform that allow the oral inhalation of a range of therapeutics.